Article info

Download PDFPDF

Anti-PD-1/anti-PD-L1 immunotherapy versus docetaxel for previously treated advanced non-small cell lung cancer: a systematic review and meta-analysis of randomised clinical trials

Authors

  1. Correspondence to Dr Allan Ramos-Esquivel; allan.ramos{at}ucr.ac.cr
View Full Text

Citation

Ramos-Esquivel A, van der Laat A, Rojas-Vigott R, et al
Anti-PD-1/anti-PD-L1 immunotherapy versus docetaxel for previously treated advanced non-small cell lung cancer: a systematic review and meta-analysis of randomised clinical trials

Publication history

  • Received June 23, 2017
  • Revised July 13, 2017
  • Accepted July 18, 2017
  • First published August 31, 2017.
Online issue publication 
August 31, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.